NCT00678145TERMINATEDanonymous

Mechanisms of Hypoglycemia Associated Autonomic Failure

Sponsor

Source record

Albert Einstein College of Medicine

Phase

Source record

PHASE2

Modality

AI-normalized

small molecule

Target

AI-normalized

naloxone, fructose, exercise, Morphine sulfate, Epinephrine

Indication / condition

AI-normalized

Diabetes Mellitus

Intervention

Source record

naloxone, fructose, exercise, Morphine sulfate, Epinephrine

Related intelligence directories

Indication directory: Diabetes Mellitus Modality directory: small molecule Target directory: naloxone

Source & freshness

Source record

NCT ID

NCT00678145

Original source

ClinicalTrials.gov

Source last updated

Detailed source ingestion pending.

Ingested at

Jul 25, 2026

Internal sync

Jul 25, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT00678145

Title

Mechanisms of Hypoglycemia Associated Autonomic Failure

Sponsor

Albert Einstein College of Medicine

Status

TERMINATED

Phase

PHASE2

Condition raw

Diabetes Mellitus, Hypoglycemia, Autonomic Failure

Condition normalized

Diabetes Mellitus, Hypoglycemia, Autonomic Failure

Modality raw

small molecule

Modality normalized

small molecule

Target raw

naloxone, fructose, exercise, Morphine sulfate, Epinephrine

Target normalized

naloxone, fructose, exercise, Morphine sulfate, Epinephrine

Interventions

naloxone, fructose, exercise, Morphine sulfate, Epinephrine

Public preview

Source record

Mechanisms of Hypoglycemia Associated Autonomic Failure is a PHASE2 clinical asset sponsored by Albert Einstein College of Medicine in Diabetes Mellitus, Hypoglycemia, Autonomic Failure. SEO and diligence focus: naloxone, fructose, exercise, Morphine sulfate, Epinephrine, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Mechanisms of Hypoglycemia Associated Autonomic Failure

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jul 28, 2026

Report code

NCT00678145-Jul 28, 2026

NCT ID

NCT00678145

Status

TERMINATED

Phase

PHASE2

Sponsor

Albert Einstein College of Medicine

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedDetailed source ingestion pending.

Internal syncJul 25, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT00678145

Indication

Diabetes Mellitus

Modality

small molecule

Target

naloxone, fructose, exercise, Morphine sulfate, Epinephrine

Intervention

naloxone, fructose, exercise, Morphine sulfate, Epinephrine

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.